---
category: listing
circular_id: 077c2a884f40cc5e
date: '2025-12-15'
description: Dr. Lal PathLabs Limited has fixed December 19, 2025 as record date for
  bonus issue of 1 equity share for every 1 existing share held, with deemed allotment
  on December 22, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={CC1487B6-53FA-42D2-8517-A51AD38059FF}&noticeno=20251215-9&dt=12/15/2025&icount=9&totcount=71&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Significant corporate action affecting all shareholders with 1:1 bonus
  ratio, doubling outstanding shares. High impact on liquidity and shareholding structure.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251215-9&attachedId=5e437086-f919-4b2c-9ebb-696d54e556b6
processing:
  attempts: 1
  content_hash: 03c2841ba2656048
  processed_at: '2025-12-15T15:57:28.108177'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-15T08:49:29+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={CC1487B6-53FA-42D2-8517-A51AD38059FF}&noticeno=20251215-9&dt=12/15/2025&icount=9&totcount=71&flag=0
severity: medium
source: bse
stocks:
- LALPATHLAB
tags:
- bonus-issue
- equity-shares
- corporate-action
- allotment
- record-date
title: Bonus Issue of Dr. Lal PathLabs Limited - 1:1 Ratio
---

## Summary

Dr. Lal PathLabs Limited (Scrip Code: 539524/139524) has confirmed the record date of December 19, 2025 for issuing bonus equity shares in the ratio of 1:1. The company will issue 83,775,510 bonus equity shares of Rs. 10/- each, with deemed allotment on December 22, 2025 and trading commencing on December 23, 2025. The company has obtained In-Principle Approval from BSE and uploaded the Scrutinizer's Report as required.

## Key Points

- Bonus ratio: 1 new equity share for every 1 existing equity share held
- Face value: Rs. 10/- per share
- Total bonus shares to be issued: 83,775,510 equity shares
- ISIN: INE600L01024
- In-Principle Approval obtained from BSE
- Scrutinizer's Report uploaded 3 working days before record date
- Bonus shares will be credited by 12 PM on deemed allotment date
- Distinctive number range: 83775511 to 167551020

## Regulatory Changes

No regulatory changes introduced by this circular.

## Compliance Requirements

- Company undertakes to credit bonus shares to beneficiary accounts by 12 PM on December 22, 2025
- Scrutinizer's Report has been uploaded on BSE Listing Centre as required
- In-Principle Approval already obtained from BSE
- Compliance with all pre-requisites for bonus issue completion

## Important Dates

- **Record Date**: Friday, December 19, 2025
- **Deemed Date of Allotment**: Monday, December 22, 2025 (credit by 12 PM)
- **Effective Listing Date**: Tuesday, December 23, 2025 (trading commences)

## Impact Assessment

**Market Impact**: High impact corporate action that will double the outstanding equity shares of Dr. Lal PathLabs. The 1:1 bonus ratio is highly favorable for existing shareholders.

**Shareholder Impact**: All shareholders on record as of December 19, 2025 will receive one additional share for each share held, effectively doubling their shareholding without any cash outflow.

**Liquidity Impact**: Expected to improve stock liquidity and affordability as the share price will adjust post-bonus, potentially attracting more retail investors.

**Operational Impact**: The issuance of 83,775,510 new shares will significantly increase the company's equity base and improve free float if applicable.